BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Treatment
10 results:

  • 1. Loss of bap1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland.
    Quiroga EF; Connor PR; Rooper L; Moreno MA; Nix JS
    Head Neck Pathol; 2023 Sep; 17(3):851-854. PubMed ID: 37594632
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline bap1 Mutations.
    Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. bap1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.
    Wang F; Luo M; Qu H; Cheng Y
    FEBS Open Bio; 2021 May; 11(5):1497-1503. PubMed ID: 33529461
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
    Carbone M; Adusumilli PS; Alexander HR; Baas P; Bardelli F; Bononi A; Bueno R; Felley-Bosco E; Galateau-Salle F; Jablons D; Mansfield AS; Minaai M; de Perrot M; Pesavento P; Rusch V; Severson DT; Taioli E; Tsao A; Woodard G; Yang H; Zauderer MG; Pass HI
    CA Cancer J Clin; 2019 Sep; 69(5):402-429. PubMed ID: 31283845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent bap1, PIK3CA, and other actionable genomic alterations.
    Wang K; McDermott JD; Schrock AB; Elvin JA; Gay L; Karam SD; Raben D; Somerset H; Ali SM; Ross JS; Bowles DW
    Ann Oncol; 2017 Apr; 28(4):748-753. PubMed ID: 28327999
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
    Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
    J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Uveal melanoma: From diagnosis to treatment and the science in between.
    Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
    Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer.
    Murphy CT; Devarajan K; Wang LS; Mehra R; Ridge JA; Fundakowski C; Galloway TJ
    Oral Oncol; 2015 Nov; 51(11):1034-1040. PubMed ID: 26410020
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
    Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
    Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.